MIND Prize Initiative
The MIND Prize supports innovative, high-risk neuroscience research on neurodegenerative diseases by early-to-mid-career U.S. investigators, encouraging bold interdisciplinary approaches for transformative breakthroughs.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026 (Letter of Intent, projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; up to 10% indirect costs included)
Summary: Supports high-risk, high-reward neuroscience research by early-to-mid-career independent U.S. investigators, with a focus on neurodegenerative diseases.
Key Information: Forecasted cycle; eligibility limited to 1–8 years independent experience by May 2026.
Description
The MIND Prize Initiative is designed to catalyze innovative, high-impact research in neuroscience, particularly targeting neurodegenerative diseases such as Alzheimer’s Disease and related dementias. The program supports early-to-mid-career independent investigators in the United States who propose bold, interdisciplinary projects that may not yet have substantial preliminary data but show the potential for transformative advances. Awardees join a collaborative network, benefit from professional development opportunities, and receive significant funding to pursue projects that challenge conventional paradigms in brain science.
